New cancer subtype may illuminate treatment strategy
Researchers have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth. This discovery opens the door to the development of therapies that treat this specific disease.
Materials provided by Weill Cornell Medicine. Note: Content may be edited for style and length.
Source link aaaaa